Loading clinical trials...
Loading clinical trials...
A Single-site, Open-Label, Pilot Study to Evaluate the Benefit of RUCONEST® in Subjects Who Experience ADRs Related to IVIG Infusions
Conditions
Interventions
C1-esterase inhibitor [recombinant] (C1-INH-R)
Locations
1
United States
IMMUNOe Research Centers
Centennial, Colorado, United States
Start Date
June 13, 2018
Primary Completion Date
December 1, 2019
Completion Date
March 1, 2020
Last Updated
February 15, 2021
Lead Sponsor
IMMUNOe Research Centers
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions